ACAD DCF Valuation - ACADIA Pharmaceuticals Inc

Dashboard Market News Investing Ideas Pricing

Watchlist Manager

Watchlist

Price: 21.62 USD 0.09% Market Closed

Market Cap: $3.7B

	ACADIA Pharmaceuticals Inc NASDAQ:ACAD	US
C	CD Projekt SA WSE:CDR	PL
D	DBV Technologies SA LSE:0QAJ	FR
	LNA Sante SA PAR:LNA	FR
	Hyatt Hotels Corp NYSE:H	US
	Confluent Inc NASDAQ:CFLT	US
B	Baltic Classifieds Group PLC LSE:BCG	UK
	Lumentum Holdings Inc NASDAQ:LITE	US
	Valeo SE PAR:FR	FR
	Kasumigaseki Capital Co Ltd TSE:3498	JP
	Rio Tinto Ltd ASX:RIO	AU
T	Tokai Holdings Corp TSE:3167	JP
	Reading International Inc NASDAQ:RDI	US
	Rakuten Group Inc TSE:4755	JP
S	SML Isuzu Ltd NSE:SMLISUZU	IN
A	Amazon.com Inc MIL:AMZN	US
	Cheil Worldwide Inc KRX:030000	KR
	Natwest Group PLC LSE:NWG	UK
T	TSH Resources Bhd KLSE:TSH	MY
	Deutsche Bank AG XETRA:DBK	DE
	Inficon Holding AG SIX:IFCN	CH
	Solid State PLC LSE:SOLI	UK
	ITEQ Corp TWSE:6213	TW
A	Aem Holdings Ltd SGX:XWA	SG

ACAD's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.